Today's Edition Local Missouri National World Opinion Obits Sports GoMidMo Events Classifieds Newsletters Contests Special Sections Jobs
ADVERTISEMENT
ADVERTISEMENT
story.lead_photo.caption FILE - This June 25, 2019, file photo shows the sign outside a Walgreens Pharmacy in Pittsburgh. Walgreens Boots Alliance will sell its pharmaceutical wholesaler business to AmerisourceBergen in $6.5 billion cash and stock deal. The drugstore chain says the deal will let it invest in and focus on its retail business, which has been hurt by sales declines during the COVID-19 pandemic. (AP Photo/Gene J. Puskar, File)

Walgreens Boots Alliance will sell its pharmaceutical wholesale business to AmerisourceBergen in a $6.5 billion cash and stock deal.

Pharmaceutical wholesalers essentially act as middlemen, purchasing drugs from manufacturers and then distributing them to customers like drugstore chains, hospitals and doctor’s offices.

Walgreens said Wednesday that the deal will allow it to focus more on expanding its core retail pharmacy business which, like others, has been rattled by the COVID-19 pandemic.

Drugstore chains and other retailers were hit hard, particularly last spring, when the pandemic forced shoppers to stay home and away from their stores.

Walgreens estimated in October that the pandemic shaved about $520 million from its operating income in its final quarter of fiscal 2020. However, the drugstore chain also grew sales and prescriptions in the United States and saw some improvement through its Boots stores in the United Kingdom.

Deerfield, Illinois-based Walgreens Boots Alliance Inc. runs more than 21,000 stores mainly in the United States and United Kingdom. Drugstores are the main focus of its business, unlike main rival CVS Health Corp., which also operates large insurance and pharmacy benefit management businesses.

AmerisourceBergen will pay nearly $6.3 billion in cash and 2 million shares of its common stock for Walgreens’ Alliance Healthcare business in a deal the companies expect to close by September. Walgreens already owns a nearly 30 percent stake in AmerisourceBergen.

Alliance Healthcare supplies more than 115,000 pharmacies, physicians and health centers in Europe and Egypt.

The companies also said Wednesday that they will extend their U.S. distribution agreement by three years, until 2029.

Walgreens said in November that it was combining its wholesale business in Germany with McKesson Corp., and it would control 70 percent of that venture. A Walgreens spokesman said Wednesday that the McKesson joint venture was not part of the Amerisource deal.

Shares of AmerisourceBergen Corp., based in Chesterbrook, Pennsylvania, jumped more than 8 percent to $105.78 Wednesday afternoon. Walgreens shares rose more than 4 percent to $43.10. Both eclipsed the more than 1 percent increase from the Dow Jones industrial average, of which Walgreens is a component.

Walgreens will report results from its fiscal first quarter today.

COMMENTS - It looks like you're using Internet Explorer, which isn't compatible with our commenting system. You can join the discussion by using another browser, like Firefox or Google Chrome.
It looks like you're using Microsoft Edge. Our commenting system is more compatible with Firefox and Google Chrome.
ADVERTISEMENT
ADVERTISEMENT